These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tenecteplase for treatment of acute myocardial infarction. Turcasso NM; Nappi JM Ann Pharmacother; 2001 Oct; 35(10):1233-40. PubMed ID: 11675853 [TBL] [Abstract][Full Text] [Related]
23. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]
24. Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose. Rubboli A; Gatti C; Spinolo L; Parollo R; Spitali G; Maresta A Minerva Cardioangiol; 2006 Feb; 54(1):131-7. PubMed ID: 16467747 [TBL] [Abstract][Full Text] [Related]
25. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. ADVANCE MI Investigators Am Heart J; 2005 Jul; 150(1):116-22. PubMed ID: 16084157 [TBL] [Abstract][Full Text] [Related]
26. Tenecteplase in the treatment of acute myocardial infarction. Chandra KS; Jariwala P; Lathi P Indian Heart J; 2009; 61(5):437-42. PubMed ID: 20635758 [No Abstract] [Full Text] [Related]
27. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Antman EM; Louwerenburg HW; Baars HF; Wesdorp JC; Hamer B; Bassand JP; Bigonzi F; Pisapia G; Gibson CM; Heidbuchel H; Braunwald E; Van de Werf F Circulation; 2002 Apr; 105(14):1642-9. PubMed ID: 11940541 [TBL] [Abstract][Full Text] [Related]
28. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780 [TBL] [Abstract][Full Text] [Related]
29. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864 [TBL] [Abstract][Full Text] [Related]
30. [Optimal thrombolysis]. Nordt TK; Bode C Z Kardiol; 2001 Aug; 90(8):591-5. PubMed ID: 11565215 [TBL] [Abstract][Full Text] [Related]
31. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction. Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430 [TBL] [Abstract][Full Text] [Related]
32. A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction. Tsikouris JP; Tsikouris AP Pharmacotherapy; 2001 Feb; 21(2):207-17. PubMed ID: 11213858 [TBL] [Abstract][Full Text] [Related]
33. Alteplase and tenecteplase: applications in the peripheral circulation. Semba CP; Sugimoto K; Razavi MK; Tech Vasc Interv Radiol; 2001 Jun; 4(2):99-106. PubMed ID: 11981795 [TBL] [Abstract][Full Text] [Related]
34. One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. Sinnaeve P; Alexander J; Belmans A; Bogaerts K; Langer A; Diaz R; Ardissino D; Vahanian A; Pehrsson K; Armstrong P; Van de Werf F; Am Heart J; 2003 Jul; 146(1):27-32. PubMed ID: 12851604 [TBL] [Abstract][Full Text] [Related]
35. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022 [TBL] [Abstract][Full Text] [Related]
36. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]